금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Update: Technology Leads US Equity Indexes Higher While Traders Weigh Escalation in Middle East
(Updates with index/price moves, macroeconomic data, and company/geopolitical news from the first pa...
U.S. Says China Has Slashed Iranian Oil Purchases by 40%
The United States says its campaign to choke off Iran's oil revenue may finally be showing results w...
Trump vows to attack Iranian nuclear facility as Middle East war escalates
Goldman Sachs warns oil could jump to $120 per barrel if Strait of Hormuz remains ‘disrupted’...
Bank ETF Showdown: Invesco Crushes iShares
Lower concentration risk and deeper liquidity set these two financial sector ETFs apart.
What Is the Vanguard Energy ETF (VDE) and Who Should Buy It?
Energy stocks account for only 3% of the S&P 500, which could make this ETF a poor choice for many investors.
Crash Warning: Barchart’s Ultimate Trader Cheat Sheet Alerted Me That Even Mega-Cap Tech Stocks Are Starting to Deteriorate
You can easily replicate these watchlists on Barchart.
State Street SPDR vs. iShares: Which Bank ETF Wins This Showdown?
Take concentration risk and amplify it, and one ETF ends up looking far more attractive.
SPDR vs. iShares: Which REIT ETF Comes Out on Top?
Concentration risk at one of these funds may cause some investors to hesitate.
Vanguard's VONG or iShares' IJT: Which Growth ETF Should Long-Term Investors Choose?
Compare sector exposure, risk profiles, and income potential as these two growth ETFs take different approaches to capturing U.S. market gains.
AbbVie said to be nearing a $10.9B deal to buy Apogee Therapeutics
Fidelity's FIGB or Vanguard's VGIT: Which Bond ETF Is the Better Buy Right Now?
Compare portfolio breadth, risk profiles, and long-term returns to see which fund may better fit your fixed-income strategy.
SCHD vs. HDV: Which Dividend ETF Is the Better Buy for Long-Term Investors?
Sector mix and risk profiles differ sharply between these popular income funds.
Did Anthropic talk its way into an AI export ban?
FT analysis shows company warned about dangers of advanced AI far more than rival OpenAI this year
Why I Think This Vanguard ETF Will Beat the S&P 500 Over the Next 10 Years
International stocks are trading for a steep discount, and here's a great way to invest.
Scott Galloway says GLP-1 drugs are a 'silver bullet' for America's woes, if we're not 'stupid enough' to get in the way
The drug has shown itself to be effective for weight loss — but its high price is making it a hard sell for many would-be users.